Strategic Considerations for Selecting Artificial Intelligence Solutions for Institutional Integration: A Single-Center Experience
- PMID: 40206525
- PMCID: PMC11975996
- DOI: 10.1016/j.mcpdig.2024.10.004
Strategic Considerations for Selecting Artificial Intelligence Solutions for Institutional Integration: A Single-Center Experience
Abstract
Artificial intelligence (AI) promises to revolutionize health care. Early identification of disease, appropriate test selection, and automation of repetitive tasks are expected to optimize cost-effective care delivery. However, pragmatic selection and integration of AI algorithms to enable this transformation remain challenging. Health care leaders must navigate complex decisions regarding AI deployment, considering factors such as cost of implementation, benefits to patients and providers, and institutional readiness for adoption. A successful strategy needs to align AI adoption with institutional priorities, select appropriate algorithms to be purchased or internally developed, and ensure adequate support and infrastructure. Further, successful deployment requires algorithm validation and workflow integration to ensure efficacy and usability. User-centric design principles and usability testing are critical for AI adoption, ensuring seamless integration into clinical workflows. Once deployed, continuous improvement processes and ongoing algorithm support ensure continuous benefits to the clinical practice. Vigilant planning and execution are necessary to navigate the complexities of AI implementation in the health care environment. By applying the framework outlined in this article, institutions can navigate the ever-evolving and complex environment of AI in health care to maximize the benefits of these innovative technologies.
© 2024 The Authors.
Conflict of interest statement
Dr Blezek reports 25% stock interest in Flow Sigma. Dr Callstrom reports royalty from UpToDate; consulting fees from 10.13039/100004325AstraZeneca, Replimune, Pulse Biosciences, and Varian Medical Systems; reports participation in the advisory board of Boston Scientific; and was the president of the Society of Interventional Oncology. The other authors report no competing interests.
Figures



References
-
- Altman R. Artificial intelligence in healthcare: benefits, myths, and limitations. G2. https://www.g2.com/articles/artificial-intelligence-in-healthcare-benefi...
-
- Fornell D. FDA has now cleared 700 AI healthcare algorithms, more than 76% in radiology. Innovate Healthcare. Health Imaging. https://healthimaging.com/topics/artificial-intelligence/fda-has-now-cle...
-
- Ali O., Abdelbaki W., Shrestha A., Elbasi E., Alryalat M.A.A., Dwivedi Y.K. A systematic literature review of artificial intelligence in the healthcare sector: benefits, challenges, methodologies, and functionalities. J Innov Knowl. 2023;8(1) doi: 10.1016/j.jik.2023.100333. - DOI
Publication types
LinkOut - more resources
Full Text Sources